Obesity-related derangements of coagulation and fibrinolysis a study of obesity-discordant monozygotic twin pairs

Obesity

Volumn 20, Issue 1, 2012, Pages 88-94

  Kaye, Sanna M ^a   Pietiläinen, Kirsi H ^a,b   Kotronen, Anna ^a   Joutsi Korhonen, Lotta ^a   Kaprio, Jaakko ^b,c   Yki Järvinen, Hannele ^a   Silveira, Angela ^d   Hamsten, Anders ^d   Lassila, Riitta ^a   Rissanen, Aila ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; FIBRINOGEN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ABDOMINAL FAT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FIBRINOLYSIS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MONOZYGOTIC TWINS; OBESITY; PROTEIN BLOOD LEVEL; TWIN CONCORDANCE; TWIN DISCORDANCE;

ABDOMINAL FAT; ABSORPTIOMETRY, PHOTON; ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; FACTOR IX; FACTOR XI; FACTOR XII; FASTING; FATTY LIVER; FEMALE; FIBRINOGEN; FIBRINOLYSIS; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSIS; TWINS, MONOZYGOTIC;

EID: 84655163240     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.287     Document Type: Article

References (55)

1. Anfossi G, Russo I, Trovati M. Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis 2009;19:440-449.
2. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002;3:85-101. (Pubitemid 34827150)
3. Nagai N, Hoylaerts MF, Cleuren AC, Van Vlijmen BJ, Lijnen HR. Obesity promotes injury induced femoral artery thrombosis in mice. Thromb Res 2008;122:549-555.
4. Rosito GA, D'Agostino RB, Massaro J et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 2004;91:683-689. (Pubitemid 38477447)
5. Lijnen HR. Role of fibrinolysis in obesity and thrombosis. Thromb Res 2009;123(Suppl 4):S46-S49.
6. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003;144:2195-2200. (Pubitemid 36629866)
7. Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003;89:993-997. (Pubitemid 37046828)
8. Balagopal P, George D, Sweeten S et al. Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children. J Thromb Haemost 2008;6:1296-1303. (Pubitemid 352022550)
9. Hämäläinen H, Rönnemaa T, Virtanen A et al.; Finnish Diabetes Prevention Study Group. Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study. Diabetologia 2005;48:2248-2253. (Pubitemid 41618914)
10. Souto JC, Almasy L, Blangero J et al. Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hematostatis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia. Thromb Haemost 2001;85:88-92. (Pubitemid 32050948)
11. de Lange M, Snieder H, Ariëns RA, Spector TD, Grant PJ. The genetics of haemostasis: a twin study. Lancet 2001;357:101-105. (Pubitemid 32094912)
12. Hamsten A, Iselius L, de Faire U, Blombäck M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987;2:988-991.
13. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-1532. (Pubitemid 30120809)
14. Vossen CY, Callas PW, Hasstedt SJ et al. A genetic basis for the interrelation of coagulation factors. J Thromb Haemost 2007;5:1930-1935. (Pubitemid 47288952)
15. Hong Y, Pedersen NL, Egberg N, de Faire U. Moderate genetic influences on plasma levels of plasminogen activator inhibitor-1 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor-1, triglycerides, and body mass index. Arterioscler Thromb Vasc Biol 1997;17:2776-2782. (Pubitemid 28016021)
16. Kaprio J, Pulkkinen L, Rose RJ. Genetic and environmental factors in health-related behaviors: studies on Finnish twins and twin families. Twin Res 2002;5:366-371. (Pubitemid 35315485)
17. Pietiläinen KH, Rissanen A, Kaprio J et al. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 2005;288:E768-E774. (Pubitemid 40397213)
18. Pietiläinen KH, Rissanen A, Laamanen M et al. Growth patterns in young adult monozygotic twin pairs discordant and concordant for obesity. Twin Res 2004;7:421-429. (Pubitemid 39390136)
19. Gertow K, Pietiläinen KH, Yki-Järvinen H et al. Expression of fatty-acidhandling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia 2004;47:1118-1125. (Pubitemid 38918172)
20. Pietiläinen KH, Naukkarinen J, Rissanen A et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008;5:e51.
21. Pietrobelli A, Formica C, Wang Z, Heymsfield SB. Dual-energy X-ray absorptiometry body composition model: review of physical concepts. Am J Physiol 1996;271:E941-E951.
22. Ryysy L, Häkkinen AM, Goto T et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000;49:749-758. (Pubitemid 30339990)
23. Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 2007;293:E1709-E1715. (Pubitemid 350255123)
24. Sutinen J, Häkkinen AM, Westerbacka J et al. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. AIDS 2002;16:2183-2193. (Pubitemid 35387273)
25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223. (Pubitemid 9249478)
26. Yki-Järvinen H, Young AA, Lamkin C, Foley JE. Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 1987;79:1713-1719. (Pubitemid 17117278)
27. Rao JNK, Scott AJ. On chi-squared tests for multiway contingency tables with cell propotions estimated from survey-data. Ann Statist 1984;12:46-60.
28. Danesh J, Lewington S, Thompson SG et al.; Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-1809. (Pubitemid 41434626)
29. Kaptoge S, White IR, Thompson SG et al.; Fibrinogen Studies Collaboration. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007;166:867-879. (Pubitemid 47511690)
30. Lubrano C, Cornoldi A, Pili M et al. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up. Int J Obes Relat Metab Disord 2004;28:1600-1606. (Pubitemid 39564340)
31. Sugrue DD, Trayner I, Thompson GR et al. Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia. Br Heart J 1985;53:265-268. (Pubitemid 15052274)
32. de Lange M, Snieder H, Ariëns RA et al. The relation between insulin resistance and hemostasis: pleiotropic genes and common environment. Twin Res 2003;6:152-161. (Pubitemid 36427903)
33. Frankel DS, Meigs JB, Massaro JM et al. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study. Circulation 2008;118:2533-2539.
34. Renné T, Nieswandt B, Gailani D. The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol Dis 2006;36:148-151.
35. Tucker EI, Marzec UM, White TC et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 2009;113:936-944.
36. Bereczky Z, Katona E, Muszbek L. Fibrin stabilization (factor XIII), fibrin structure and thrombosis. Pathophysiol Haemost Thromb 2003;33:430-437. (Pubitemid 40278720)
37. Gui T, Reheman A, Funkhouser WK et al. In vivo response to vascular injury in the absence of factor IX: examination in factor IX knockout mice. Thromb Res 2007;121:225-234. (Pubitemid 350138073)
38. Wannamethee SG, Whincup PH, Rumley A, Lowe GD. Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J Thromb Haemost 2007;5:1637-1643. (Pubitemid 47091404)
39. Barillari G, Fabbro E, Pasca S, Bigotto E. Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population. Blood Coagul Fibrinolysis 2009;20:290-296.
40. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003;89:601-609. (Pubitemid 36456957)
41. Kohler HP, Carter AM, Stickland MH, Grant PJ. Levels of activated FXII in survivors of myocardial infarction-association with circulating risk factors and extent of coronary artery disease. Thromb Haemost 1998;79:14-18. (Pubitemid 28037048)
42. Naukkarinen J, Surakka I, Pietiläinen KH et al. Use of genome-wide expression data to mine the "Gray Zone" of GWA studies leads to novel candidate obesity genes. PLoS Genet 2010;6:e1000976.
43. Faber DR, de Groot PG, Visseren FL. Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev 2009;10:554-563.
44. Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ. Obesity and thrombosis. Eur J Vasc Endovasc Surg 2007;33:223-233. (Pubitemid 46076268)
45. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000;152:897-907.
46. Kampoli AM, Tousoulis D, Antoniades C, Siasos G, Stefanadis C. Biomarkers of premature atherosclerosis. Trends Mol Med 2009; 15:323-332.
47. Compher C, Badellino KO. Obesity and inflammation: lessons from bariatric surgery. JPEN J Parenter Enteral Nutr 2008;32:645-647.
48. Bladbjerg EM, de Maat MP, Christensen K et al. Genetic influence on thrombotic risk markers in the elderly-a Danish twin study. J Thromb Haemost 2006;4:599-607.
49. Hong Y, Pedersen NL, Egberg N, de Faire U. Genetic effects for plasma factor VII levels independent of and in common with triglycerides. Thromb Haemost 1999;81:382-386. (Pubitemid 29116608)
50. Tarumi T, Kravtsov DV, Zhao M, Williams SM, Gailani D. Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha) is required for hepatocyte-specific expression of factor XI. J Biol Chem 2002;277:18510-18516. (Pubitemid 34952400)
51. Inoue Y, Peters LL, Yim SH, Inoue J, Gonzalez FJ. Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression. J Mol Med 2006;84:334-344.
52. Hoag H, Gore J, Barry D, Mueller C. Gene therapy expression vectors based on the clotting Factor IX promoter. Gene Ther 1999;6:1584-1589. (Pubitemid 29465517)
53. Dimova EY, Kietzmann T. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost 2008;100:992-1006.
54. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK. LDL receptorrelated protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 2008;88:887-918.
55. Strickland DK, Ranganathan S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemost 2003;1:1663-1670.